Skip to main content

FOLFOX plus cetuximab produced ORR of 77% in cardia, esophageal cancer

SAN FRANCISCO – Chemoradiation with FOLFOX and cetuximab was effective in adults with locally advanced cardia and esophageal cancer in a phase 2 study, according to Aimery de Gramont, MD. Now, researchers want to see the regimen evaluated in a phase 3 trial.

http://www.hemonctoday.com/article.aspx?rid=79707

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2022 Esophageal Cancer Education Foundation- by domino